FIELD: medicine.
SUBSTANCE: invention concerns experimental medicine, particularly cardiology, and can be applied in experimental biology and medicine for correction of structural vessel wall alteration in post-perfusion period. Correction of structural alteration of main blood vessels in experiment involves intravenous meksidol introduction after rehabilitation in fractions each 20 minutes in amount of 25 mg/kg.
EFFECT: extended range of agents for correction and prevention of re-perfusion complications in main blood vessels, reduced volume of binding tissue elements in vessel walls.
2 tbl, 7 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ESTIMATING EFFICIENCY OF ENDOTHELIOTROPIC THERAPY AFTER RECONSTRUCTIVE OPERATIONS ON ARTERIES | 2015 |
|
RU2611386C2 |
| WAY OF CORRECTION OF ENDOTHELIAL DYSFUNCTION | 2007 |
|
RU2359686C2 |
| METHOD FOR RECONSTRUCTING MAIN ARTERIAL VESSELS IN CASE OF THEIR ATHEROSCLEROTIC LESION | 2006 |
|
RU2311139C1 |
| METHOD FOR SIMULATING RENOPARENCHYMATOUS ARTERIAL HYPERTENSION IN RATS | 2012 |
|
RU2507593C1 |
| APPLICATION OF DINITROSYL IRON COMPLEX WITH GLUTATHIONE-GS {(GS)2FE2(NO)4} FOR THE TREATMENT OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION | 2022 |
|
RU2804734C1 |
| CARDIOVASCULAR HOMOGRAFT (VERSIONS), METHOD FOR PREPARING HOMOGRAFT, HOMOGRAFT TISSUE EXPOSURE MEDIUM (VERSIONS) | 2013 |
|
RU2525197C1 |
| FUNCTIONALLY ACTIVE BIODEGRADABLE VASCULAR PATCH FOR ARTERIAL RECONSTRUCTION | 2019 |
|
RU2707964C1 |
| METHOD OF SYSTEMIC FIBROSIS MODELLING | 2008 |
|
RU2371778C1 |
| METHOD OF CORRECTING ENDOTHELIAL DYSFUNCTION WITH AZITHROMYCIN IN MODELING OF CHRONIC GRAM-POSITIVE SEPSIS | 2009 |
|
RU2400826C1 |
| METHOD FOR DIAGNOSIS OF TRAUMATIC ENDOTHELIAL DYSFUNCTION IN COMBINED SHOCK-PRODUCING TRAUMA | 2021 |
|
RU2782135C1 |
